LIPOCINE INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • March 6th, 2017 • Lipocine Inc. • Pharmaceutical preparations • New York
Lipocine Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for Morgan BrownExecutive Employment Agreement • March 6th, 2017 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Second Amended and Restated Executive Employment Agreement (the “Agreement”), is dated March 3, 2017 and amends and restates the Amended and Restated Executive Employment Agreement made between Lipocine Inc. (the “Company”) and Morgan Brown (“Executive”) (collectively, the “Parties”), dated effective as of January 7, 2014.
EXECUTIVE EMPLOYMENT AGREEMENT for Gregory BassExecutive Employment Agreement • March 6th, 2017 • Lipocine Inc. • Pharmaceutical preparations • Utah
This Executive Employment Agreement (the “Agreement”), made between Lipocine Inc. (the “Company”) and Gregory Bass (“Executive”) (each a “Party” and collectively, the “Parties”), is effective as of March 3,2017.
